Study of Madalena for type 2 diabetes not controlled
Treatments studied
Part of Hormones & metabolism clinical trials.
This Phase 3 study tests Madalena to improve blood sugar control in adults with type 2 diabetes that hasn’t met targets despite diet, exercise, and diabetes medicines. You may join if your recent blood sugar tests and body size fall within specific ranges and you don’t have key medical exclusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult (18 years or older) and can sign consent willingly
- You have type 2 diabetes, and prior diet/exercise plus 2 diabetes medicines hasn’t met your blood sugar goals
- Your recent HbA1c is between 7.5% and 10.5%, and your fasting blood sugar is over 100 mg/dL
- Your weight measure (BMI) is over 19 and at or below 45
- You are not pregnant, and you are not breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether LID104 can improve blood sugar control and safety in people with type 2 diabetes who are not meeting their A1c goal on metformin. You may benefit if your diabetes is still too high despite diet, exercise, and the usual metformin dose.
This study tests a new medication called HM15275 to help control blood sugar in people with type 2 diabetes. The trial will check if the medication works well and is safe when added to diet, exercise, or metformin treatment.
This study tests an experimental tablet to see if it can help control blood sugar in people with type 2 diabetes. It may be an option for those who are already on metformin or managing with diet and exercise.
This Phase 3 study tests whether a program run by the Piemonte Association can improve blood sugar control in people with type 2 diabetes who haven’t reached their target after usual diet, exercise, and stable medicines. It also aims to check that the approach is safe for participants.
This Phase 3 study tests whether Berlim 25/20 can improve blood sugar control and cholesterol (LDL) in adults with type 2 diabetes who haven’t met targets despite prior lifestyle guidance and treatment. It also looks at safety, including effects on the heart and medication-related side effects.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
Hear when a new Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.